Journal article · 2022

Kinase drug discovery 20 years after imatinib

Philip Cohen, Darren A.E. Cross, Pasi Antero Janne

Nature Reviews Drug Discovery · Published 1 April 2022 · DOI 10.1038/s41573-022-00418-2

View at the publisherCite this paper

In brief

“Kinase drug discovery 20 years after imatinib” is a 2022 journal article by Philip Cohen and 2 co-authors, published in Nature Reviews Drug Discovery. OpenAlex counts 27 citations as of 19 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
27
Most cited in
2021 (5)
Authors
3

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Cohen, P., Cross, D. A., & Janne, P. A. (2022). Kinase drug discovery 20 years after imatinib. Nature Reviews Drug Discovery. https://doi.org/10.1038/s41573-022-00418-2

MLA 9

Cohen, Philip, et al. “Kinase drug discovery 20 years after imatinib.” Nature Reviews Drug Discovery, 2022. https://doi.org/10.1038/s41573-022-00418-2.

Chicago

Cohen, Philip, Darren A.E. Cross, and Pasi Antero Janne. 2022. “Kinase drug discovery 20 years after imatinib.” Nature Reviews Drug Discovery. https://doi.org/10.1038/s41573-022-00418-2.

Harvard

Cohen, P., Cross, D. A. and Janne, P. A. (2022) ‘Kinase drug discovery 20 years after imatinib’, Nature Reviews Drug Discovery. doi:10.1038/s41573-022-00418-2.

IEEE

P. Cohen, D. A. Cross, and P. A. Janne, “Kinase drug discovery 20 years after imatinib,” Nature Reviews Drug Discovery, 2022, doi: 10.1038/s41573-022-00418-2.

BibTeX

@article{cohen2022kinase,
  title     = {{Kinase drug discovery 20 years after imatinib}},
  author    = {Cohen, Philip and Cross, Darren A.E. and Janne, Pasi Antero},
  journal   = {Nature Reviews Drug Discovery},
  year      = {2022},
  doi       = {10.1038/s41573-022-00418-2},
  url       = {https://doi.org/10.1038/s41573-022-00418-2}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202155
202255
202344
202444
202555
202644

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy

  • kinase inhibitors
  • imatinib
  • drug discovery
  • tyrosine kinase inhibitors
  • cancer therapy
  • targeted therapy

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Cohen, P., Cross, D. A., & Janne, P. A. (2022). Kinase drug discovery 20 years after imatinib. Nature Reviews Drug Discovery. https://doi.org/10.1038/s41573-022-00418-2

How many times has this paper been cited?

27 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Philip Cohen, Darren A.E. Cross, Pasi Antero Janne.

What is the DOI of this paper?

10.1038/s41573-022-00418-2, permanently at https://doi.org/10.1038/s41573-022-00418-2. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.